36707892|t|Anti-malaria drug artesunate prevents development of amyloid-beta pathology in mice by upregulating PICALM at the blood-brain barrier.
36707892|a|BACKGROUND: PICALM is one of the most significant susceptibility factors for Alzheimer's disease (AD). In humans and mice, PICALM is highly expressed in brain endothelium. PICALM endothelial levels are reduced in AD brains. PICALM controls several steps in Abeta transcytosis across the blood-brain barrier (BBB). Its loss from brain endothelium in mice diminishes Abeta clearance at the BBB, which worsens Abeta pathology, but is reversible by endothelial PICALM re-expression. Thus, increasing PICALM at the BBB holds potential to slow down development of Abeta pathology. METHODS: To identify a drug that could increase PICALM expression, we screened a library of 2007 FDA-approved drugs in HEK293t cells expressing luciferase driven by a human PICALM promoter, followed by a secondary mRNA screen in human Eahy926 endothelial cell line. In vivo studies with the lead hit were carried out in Picalm-deficient (Picalm+/-) mice, Picalm+/-; 5XFAD mice and Picalmlox/lox; Cdh5-Cre; 5XFAD mice with endothelial-specific Picalm knockout. We studied PICALM expression at the BBB, Abeta pathology and clearance from brain to blood, cerebral blood flow (CBF) responses, BBB integrity and behavior. RESULTS: Our screen identified anti-malaria drug artesunate as the lead hit. Artesunate elevated PICALM mRNA and protein levels in Eahy926 endothelial cells and in vivo in brain capillaries of Picalm+/- mice by 2-3-fold. Artesunate treatment (32 mg/kg/day for 2 months) of 3-month old Picalm+/-; 5XFAD mice compared to vehicle increased brain capillary PICALM levels by 2-fold, and reduced Abeta42 and Abeta40 levels and Abeta and thioflavin S-load in the cortex and hippocampus, and vascular Abeta load by 34-51%. Artesunate also increased circulating Abeta42 and Abeta40 levels by 2-fold confirming accelerated Abeta clearance from brain to blood. Consistent with reduced Abeta pathology, treatment of Picalm+/-; 5XFAD mice with artesunate improved CBF responses, BBB integrity and behavior on novel object location and recognition, burrowing and nesting. Endothelial-specific knockout of PICALM abolished all beneficial effects of artesunate in 5XFAD mice indicating that endothelial PICALM is required for its therapeutic effects. CONCLUSIONS: Artesunate increases PICALM levels and Abeta clearance at the BBB which prevents development of Abeta pathology and functional deficits in mice and holds potential for translation to human AD.
36707892	5	12	malaria	Disease	MESH:D008288
36707892	18	28	artesunate	Chemical	MESH:D000077332
36707892	79	83	mice	Species	10090
36707892	100	106	PICALM	Gene	233489
36707892	147	153	PICALM	Gene	8301
36707892	212	231	Alzheimer's disease	Disease	MESH:D000544
36707892	233	235	AD	Disease	MESH:D000544
36707892	241	247	humans	Species	9606
36707892	252	256	mice	Species	10090
36707892	258	264	PICALM	Gene	8301
36707892	307	313	PICALM	Gene	8301
36707892	348	350	AD	Disease	MESH:D000544
36707892	359	365	PICALM	Gene	8301
36707892	392	397	Abeta	Gene	351
36707892	484	488	mice	Species	10090
36707892	500	505	Abeta	Gene	11820
36707892	542	547	Abeta	Gene	351
36707892	592	598	PICALM	Gene	8301
36707892	631	637	PICALM	Gene	8301
36707892	693	698	Abeta	Gene	11820
36707892	758	764	PICALM	Gene	8301
36707892	829	836	HEK293t	CellLine	CVCL:0045
36707892	877	882	human	Species	9606
36707892	883	889	PICALM	Gene	8301
36707892	939	944	human	Species	9606
36707892	945	952	Eahy926	CellLine	CVCL:3901
36707892	1030	1036	Picalm	Gene	233489
36707892	1048	1054	Picalm	Gene	233489
36707892	1059	1063	mice	Species	10090
36707892	1065	1071	Picalm	Gene	233489
36707892	1076	1081	5XFAD	Chemical	-
36707892	1082	1086	mice	Species	10090
36707892	1106	1110	Cdh5	Gene	12562
36707892	1116	1121	5XFAD	Chemical	-
36707892	1122	1126	mice	Species	10090
36707892	1153	1159	Picalm	Gene	233489
36707892	1181	1187	PICALM	Gene	8301
36707892	1211	1216	Abeta	Gene	11820
36707892	1363	1370	malaria	Disease	MESH:D008288
36707892	1376	1386	artesunate	Chemical	MESH:D000077332
36707892	1404	1414	Artesunate	Chemical	MESH:D000077332
36707892	1424	1430	PICALM	Gene	8301
36707892	1458	1465	Eahy926	CellLine	CVCL:3901
36707892	1520	1526	Picalm	Gene	233489
36707892	1530	1534	mice	Species	10090
36707892	1548	1558	Artesunate	Chemical	MESH:D000077332
36707892	1612	1618	Picalm	Gene	233489
36707892	1623	1628	5XFAD	Chemical	-
36707892	1629	1633	mice	Species	10090
36707892	1680	1686	PICALM	Gene	8301
36707892	1717	1724	Abeta42	Gene	351
36707892	1748	1753	Abeta	Gene	351
36707892	1758	1770	thioflavin S	Chemical	MESH:C009462
36707892	1820	1825	Abeta	Gene	11820
36707892	1842	1852	Artesunate	Chemical	MESH:D000077332
36707892	1880	1887	Abeta42	Gene	351
36707892	1940	1945	Abeta	Gene	11820
36707892	2001	2006	Abeta	Gene	11820
36707892	2031	2037	Picalm	Gene	233489
36707892	2042	2047	5XFAD	Chemical	-
36707892	2048	2052	mice	Species	10090
36707892	2058	2068	artesunate	Chemical	MESH:D000077332
36707892	2218	2224	PICALM	Gene	233489
36707892	2261	2271	artesunate	Chemical	MESH:D000077332
36707892	2275	2280	5XFAD	Chemical	-
36707892	2281	2285	mice	Species	10090
36707892	2314	2320	PICALM	Gene	233489
36707892	2375	2385	Artesunate	Chemical	MESH:D000077332
36707892	2396	2402	PICALM	Gene	233489
36707892	2414	2419	Abeta	Gene	11820
36707892	2471	2476	Abeta	Gene	11820
36707892	2514	2518	mice	Species	10090
36707892	2558	2563	human	Species	9606
36707892	2564	2566	AD	Disease	MESH:D000544
36707892	Positive_Correlation	MESH:D000077332	8301
36707892	Association	351	8301
36707892	Negative_Correlation	MESH:C009462	MESH:D000077332
36707892	Association	11820	8301
36707892	Negative_Correlation	MESH:D000544	233489
36707892	Negative_Correlation	MESH:D000077332	351
36707892	Negative_Correlation	MESH:D000077332	11820
36707892	Positive_Correlation	MESH:D000077332	233489
36707892	Negative_Correlation	MESH:D000544	8301
36707892	Negative_Correlation	MESH:D000077332	MESH:D008288

